Commensal gastrointestinal microbiota

The commensal gastrointestinal microbiota refers to the complex community of microorganisms—including bacteria, archaea, fungi, and viruses—that inhabit the human digestive tract[3][1]. These organisms have co-evolved with their host and play mutually beneficial roles in nutrient extraction (e.g., fiber fermentation, vitamin synthesis), energy balance, immune regulation, protection against pathogens, and maintenance of the intestinal epithelial barrier[1][2][6]. Disruption of this community (dysbiosis) is implicated in a wide spectrum of diseases both within and outside the gut, including inflammatory, metabolic, autoimmune, and even neurobehavioral disorders[2][3][4]. Unlike conventional therapeutic targets such as proteins or receptors, the commensal gastrointestinal microbiota is not a single molecular entity but a diverse, dynamic ecosystem whose functions are integral to health and disease. Current therapeutic strategies targeting the microbiota involve indirect modification through antibiotics, prebiotics, probiotics, or transplantation approaches rather than specific ligand binding as with traditional receptors or enzymes[1][3][2][6].

Other names

Gut microbiotaGut floraGastrointestinal microbiotaCommensal bacteria of the gutIntestinal microbiome

Modulation of adjacent host cell signaling (e.g., via short-chain fatty acids acting on G-protein coupled receptors); Altering immune responses by regulating cytokine production; Competitive exclusion of pathogens; Biotransformation of pharmaceuticals and xenobiotics